Microsoft and Meta Are Holding Their Ground in 2025—Is Now the Right Time to Invest?
As we move into 2025, two tech giants, Microsoft and Meta, continue to dominate the global digital landscape. Both companies…
Read More
Kidney disease-focused biotech Dimerix announced a US licensing deal for DMX-200! And this could be the best deal of all!
Dimerix has been targeting a US licensing deal for DMX-200 and the dreams are now a reality as of this…
Read More
4 key metrics in resources projects that investors need to be aware of
There are several key metrics in resources projects that investors considering junior mining & resources stocks need to consider. However,…
Read More